The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Oct. 19, 2016
Applicant:

Genesis Technologies Limited, Warrens, St. Michael, BB;

Inventors:

Jan-Eric Ahlfors, Laval, CA;

Rouwayda El-Ayoubi, Laval, CA;

Assignee:

Genesis Technologies Limited, Warrens, St. Michael, BB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/0775 (2010.01); C12N 5/0797 (2010.01); C12N 5/079 (2010.01); C12N 5/074 (2010.01); A61K 35/30 (2015.01); C12N 5/0789 (2010.01); C12N 5/077 (2010.01); C12N 5/0793 (2010.01); C12N 5/071 (2010.01); A61K 35/545 (2015.01);
U.S. Cl.
CPC ...
C12N 5/0662 (2013.01); A61K 35/30 (2013.01); C12N 5/0618 (2013.01); C12N 5/0619 (2013.01); C12N 5/0623 (2013.01); C12N 5/0647 (2013.01); C12N 5/0656 (2013.01); C12N 5/0657 (2013.01); C12N 5/0667 (2013.01); C12N 5/0668 (2013.01); C12N 5/0696 (2013.01); A61K 35/545 (2013.01); C12N 5/0676 (2013.01); C12N 2500/25 (2013.01); C12N 2501/06 (2013.01); C12N 2501/065 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/13 (2013.01); C12N 2501/155 (2013.01); C12N 2501/16 (2013.01); C12N 2501/395 (2013.01); C12N 2501/60 (2013.01); C12N 2501/602 (2013.01); C12N 2501/604 (2013.01); C12N 2501/727 (2013.01); C12N 2501/998 (2013.01); C12N 2506/094 (2013.01); C12N 2506/11 (2013.01); C12N 2506/1307 (2013.01); C12N 2506/1346 (2013.01); C12N 2506/1384 (2013.01); C12N 2510/00 (2013.01);
Abstract

A method of obtaining a cardiac multipotent or unipotent cell, comprising: i) providing a cell of a first type which is not a cardiac multipotent or unipotent cell; ii) introducing into the cell of a first type an agent capable of remodeling the chromatin and/or DNA of the cell, wherein the agent capable of remodeling the chromatin and/or DNA is a histone acetylator, an inhibitor of histone deacetylation, a DNA demethylator, and/or a chemical inhibitor of DNA methylation; iii) introducing into the cell of a first type a reprogramming polypeptide and/or a polynucleotide encoding said reprogramming polypeptide, wherein the reprogramming polypeptide comprises Mesp1, Brachyury (T), Nkx2.5, and/or Tbx5; and iv) placing or maintaining the cell in a cardiac cell culture medium and maintaining intracellular levels of the reprogramming polypeptide or the polynucleotide encoding the reprogramming polypeptide for a sufficient period of time to allow a cardiac multipotent or unipotent cell to be obtained.


Find Patent Forward Citations

Loading…